Skip to main content
main-content

Screening, diagnosis and staging

Screening, diagnosis and staging

09-10-2017 | Sarcoma | Article

Advantages of 18F FDG-PET/CT over Conventional Staging for Sarcoma Patients

This review surveys the promise and pitfalls of using 18F fluorodeoxyglucose-PET/CT imaging for the challenging task of diagnosing, staging and treating sarcomas.

Németh Z et al. Pathol Oncol Res 2017. doi:10.1007/s12253-017-0325-0

31-07-2017 | Atypical fibroxanthoma | Article

Conception and Management of a Poorly Understood Spectrum of Dermatologic Neoplasms: Atypical Fibroxanthoma, Pleomorphic Dermal Sarcoma, and Undifferentiated Pleomorphic Sarcoma

This review sheds light on the controversial area of atypical fibroxanthoma (AFX) and related neoplasms, focusing particularly on diagnosis and management of AFX and pleomorphic dermal sarcoma.

Soleymani T and Hollmig ST. Curr Treat Options Oncol 2017; 18: 50. doi:10.1007/s11864-017-0489-6

17-07-2017 | Soft-tissue sarcoma | Article

Cost–Effectiveness of Surveillance for Distant Recurrence in Extremity Soft Tissue Sarcoma

Results from this cost-effectiveness analysis provide new evidence in the debate on which imaging methods to use for surveillance of distant recurrence in extremity soft tissue sarcoma.

Royce TJ et al. Ann Surg Oncol 2017; 24: 3264–3270. doi:10.1245/s10434-017-5996-y

18-04-2017 | Sarcoma | Article

Uterine adenosarcoma: a review

This article reviews the current state of knowledge concerning uterine adenosarcoma and discusses the management of this rare tumor.

Nathenson MJ et al. Curr Oncol Rep 2016; 18: 68. doi:10.1007/s11912-016-0552-7

07-02-2017 | Sarcoma | Article

Metastatic biomarkers in synovial sarcoma

This review article summarizes current understanding of molecular biomarkers associated with metastatic outcomes in synovial sarcoma.

de Necochea-Campion R et al. Biomark Res 2017;5:4. doi:10.1186/s40364-017-0083-x

16-12-2016 | Sarcoma | Book chapter | Article

Natural history: Importance of size, site, histopathology

In this chapter, Brennan et al. review the natural history of soft tissue sarcoma, which is highly influenced by the site of the primary lesion, tumor histopathology, and tumor size. 

Brennan MF, Antonescu CR, Alektiar KM, & Maki RG. In: Management of Soft Tissue Sarcoma. Springer International Publishing, 2016. doi:10.1007/978-3-319-41906-0_2

25-10-2016 | Sarcoma | Article

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

This study provides a comprehensive assessment of DNA methylation heterogeneity in Ewing sarcoma.

Nat Med 2017; 23: 386–395. doi:10.1038/nm.4273

Authors:
Nathan C Sheffield, Gaelle Pierron, Johanna Klughammer, Paul Datlinger, Andreas Schönegger, Michael Schuster, Johanna Hadler, Didier Surdez, Delphine Guillemot, Eve Lapouble, Paul Freneaux, Jacqueline Champigneulle, Raymonde Bouvier, Diana Walder, Ingeborg M Ambros, Caroline Hutter, Eva Sorz, Ana T Amaral, Enrique de Álava, Katharina Schallmoser, Dirk Strunk, Beate Rinner, Bernadette Liegl-Atzwanger, Berthold Huppertz, Andreas Leithner

29-04-2016 | Sarcoma | Book chapter | Article

Soft Tissue Sarcoma

This chapter presents an overview of the  epidemiology, clinical presentation and diagnosis of soft tissue sarcomas.

Austin MT & Andrassy RJ. In: The Surgery of Childhood Tumors. Edited by Carachi R & Grosfeld JL. Springer Berlin Heidelberg, 2016. doi:10.1007/978-3-662-48590-3_20